Photo of Kevin Kiley
I United States House · District 3 · California On the 2026 ballot

Rep. Kevin Kiley

Compare
Total votes
1,860
all sessions
Attendance
99%
14 missed
Higher than 76% of chamber peers
With party
100%
of cast votes
Higher than 99% of chamber peers
Bipartisan score
1%
crosses aisle rarely
Lower than 99% of chamber peers
Sponsored
340
bills & resolutions
Lower than 85% of chamber peers
Committees
7
assignments
340 bills and resolutions

Sponsored bills

Total
340
Primary
43
Co-sponsor
297
This page
340
matching current filters
Co-sponsor HR 6666
In committee · Washington House · Co-sponsor
HIRRE Prosecutors Act of 2025

Maddy summaryThe HIRRE Prosecutors Act of 2025 establishes a federal grant program to help state, local, tribal, and territorial prosecutor offices hire, retain, and train prosecutors and support staff. It authorizes $10 million annually (2026-2030) for competitive grants, covering up to 75% of eligible costs, with preference given to rural, tribal, and areas rehiring laid-off prosecutors. Grantees must cover the remaining 25% of costs (or qualify for a waiver), and funds cannot replace existing state/local funding but must supplement it. All funded projects require data tracking and annual performance evaluations by the Attorney General.

In committee Dec 11, 2025 1 co-sponsor
Co-sponsor HR 6575
In committee · Washington House · Co-sponsor
CommonGround for Affordable Health Care Act

Maddy summaryHR 6575, the CommonGround for Affordable Health Care Act, extends enhanced premium tax credits for health insurance through 2026, directly benefiting millions of lower and middle-income Americans purchasing coverage through the ACA marketplace. The bill modifies income thresholds for premium subsidies, creating new income tiers that maintain or increase financial assistance for households earning up to 1,000% of the poverty level. It includes provisions to prevent fraud in health insurance exchanges by imposing civil penalties on agents and brokers who provide false information, and requires transparency in pharmacy benefit manager contracts to improve drug pricing accountability. The legislation also extends the annual open enrollment period for health insurance exchanges for the 2026 plan year, allowing more time for people to enroll or change coverage.

In committee Dec 10, 2025 1 co-sponsor
Co-sponsor HR 1069
Passed · Washington House · Co-sponsor
PROTECT Our Kids Act

Maddy summaryHR 1069, the PROTECT Our Kids Act, prohibits federal funding for elementary and secondary schools that partner with Chinese government-funded programs like Confucius Institutes or Confucius Classrooms. The bill bans funds under applicable federal education programs from schools having such partnerships, effective one year after enactment. Schools with existing contracts before the bill's passage may request waivers by proving the partnership benefits students and supports U.S. security, though waivers expire when contracts end. The law directly affects schools receiving federal education funds and requires schools to comply within 90 days of enactment.

Passed Dec 4, 2025 1 co-sponsor
Primary HR 6402
In committee · Washington House · Lead sponsor
Ensuring Safe and Ethical AI Development Through SAFE AI Research Grants

Maddy summaryHR 6402 establishes a federal grant program administered by the National Academy of Sciences to fund research on developing "safe AI models" and mitigating AI risks. The program requires the Director to create public guiding principles for AI safety through stakeholder input, then submit a detailed proposal within one year outlining grant structure, research priorities, and evaluation methods. It directly affects researchers and institutions seeking federal funding for AI safety studies, not end-users or specific AI products. Key provisions include mandatory public input on ethical guidelines, a requirement to assess existing AI models' safety features, and a timeline for implementing the grant program. The bill focuses on research funding, not regulation of AI technology or deployment.

In committee Dec 3, 2025 0 co-sponsors
Co-sponsor HRES 920
In committee · Washington House · Co-sponsor
Celebrating the 50th anniversary of the Individuals with Disabilities Education Act on November 29, 2025, and recognizing its transformative impact on the education of children with disabilities.

Maddy summaryHRES 920 is a ceremonial resolution celebrating the 50th anniversary of the Individuals with Disabilities Education Act (IDEA) on November 29, 2025. It recognizes IDEA’s historical impact - establishing the right to free, appropriate public education in the least restrictive environment for children with disabilities - and notes how it transformed access to education after over 1 million children were previously excluded from schools. The resolution does not create new policy or funding; it solely commemorates IDEA’s legacy, honors the students and families it has served, and acknowledges educators and advocates who advanced its implementation. This is a symbolic gesture with no direct effect on current law or services.

In committee Dec 2, 2025 1 co-sponsor
Co-sponsor HR 1262
Passed · Washington House · Co-sponsor
Mikaela Naylon Give Kids a Chance Act

Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research.  Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research.  The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)

Passed Dec 2, 2025 1 co-sponsor
Co-sponsor HRES 906
In committee · Washington House · Co-sponsor
Amending the Rules of the House of Representatives to require a supermajority vote of Members present and voting to subject a Member, Delegate, or Resident Commissioner to the censure or disapproval of the House, or removal from committee membership.

Maddy summaryHRES 906 would change House rules to require a 60% vote of members present and voting to censure, disapprove, or remove any House member, delegate, or resident commissioner from committee assignments. Currently, a simple majority (50%+1) could trigger these actions, but this bill raises the threshold to a supermajority. The change applies directly to all voting members of the House and affects disciplinary procedures for members. This is a procedural rule change that makes it harder to take formal disciplinary actions against House members.

In committee Nov 21, 2025 1 co-sponsor
Co-sponsor HR 6210
In committee · Washington House · Co-sponsor
Senior Savings Protection Act

Maddy summaryHR 6210, the Senior Savings Protection Act, extends mandatory annual funding for key senior assistance programs through fiscal year 2030. It allocates $15 million each year for State Health Insurance Assistance Programs, $15 million for Area Agencies on Aging, $5 million for Aging and Disability Resource Centers, and $15 million for outreach coordination efforts. These funds directly support low-income seniors by expanding access to counseling, benefits enrollment help, and program information through state and local agencies. The bill makes no new eligibility rules but ensures sustained financial support for existing services that help seniors navigate healthcare and social programs.

In committee Nov 20, 2025 1 co-sponsor
Co-sponsor HR 6130
In committee · Washington House · Co-sponsor
ASAP Act

Maddy summaryThis bill would require Medicare to cover early detection screening tests for Alzheimer's disease and related dementias starting January 1, 2028. It defines eligible tests as FDA-cleared genomic blood tests, blood product analyses, or equivalent medical imaging methods (like protein expression or whole genome sequencing) that detect pre-symptomatic or early-stage conditions. Medicare beneficiaries would receive this coverage without cost-sharing for these specific screenings. The bill amends Medicare coverage rules to explicitly include these tests under Section 1861(nnn) of the Social Security Act.

In committee Nov 19, 2025 1 co-sponsor
Co-sponsor HR 6126
In committee · Washington House · Co-sponsor
United States Foreign Service Commemorative Coin Act

Maddy summaryHR 6126 authorizes the minting of commemorative coins to mark the 100th anniversary of the U.S. Foreign Service (established in 1924). It specifies three coin types: up to 50,000 $5 gold coins (90% gold), 400,000 $1 silver coins (90% silver), and 750,000 half-dollar coins, all to be sold during 2029. A surcharge of $35 per gold coin, $10 per silver coin, and $5 per half-dollar is added to the sale price, with all surcharge funds directed to the Association for Diplomatic Studies and Training to support its diplomatic history preservation work. The coins must include standard inscriptions (e.g., "Liberty," "United States of America") and will be legal tender, but the bill does not create new policy or affect government operations.

In committee Nov 19, 2025 1 co-sponsor
Showing 51 to 60 of 340 bills
Previous 1 5 6 7 34 Next